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Abstract: Propolis is a multi-functional bee product rich in polyphenols. In this study, the inhibitory effect of Anatolian propolis against
SARS-coronavirus-2 (SARS-CoV-2) was investigated in vitro and in silico. Raw and commercial propolis samples were used, and both
samples were found to be rich in caffeic acid, p-coumaric acid, ferulic acid, t-cinnamic acid, hesperetin, chrysin, pinocembrin, and
caffeic acid phenethyl ester (CAPE) at HPLC-UV analysis. Ethanolic propolis extracts (EPE) were used in the ELISA screening test
against the spike S1 protein (SARS-CoV-2): ACE-2 interaction for in vitro study. The binding energy values of these polyphenols to the
SARS-CoV-2 spike and ACE-2 protein were calculated separately with a molecular docking study using the AutoDock 4.2.6 program.
In addition, the pharmacokinetics and drug-likeness properties of these eight polyphenols were calculated according to the SwissADME
tool. The binding energy value of pinocembrin was highest in both receptors, followed by chrysin, CAPE, and hesperetin. Based on the
in silico modeling and ADME (absorption, distribution, metabolism, and excretion) behaviors of the eight polyphenols, the compounds
exhibited the potential ability to act effectively as novel drugs. The findings of both studies showed that propolis has a high inhibitory
potential against the Covid-19 virus. However, further studies are now needed.
Key words: Propolis, Covid-19, SARS-CoV-2, pinocembrin, molecular docking

1. Introduction
Severe acute respiratory syndrome (SARS) coronavirus-2
(SARS-CoV-2) is responsible for the coronavirus
(COVID-19) pandemic. Coronavirus ranks as the seventh
largest family infecting humans after SARS coronavirus and
Middle East respiratory syndrome (MERS) coronavirus
(Bachevski et al., 2020; Zhu et al., 2020). Compared with
other viruses, coronavirus has high transmissibility and
infectivity. It is mostly spread through the respiratory tracts
and is transmitted directly or indirectly, generally through
the mucous membranes, nose, mouth and eyes. Until an
effective vaccine or medicine was found, many physical and
chemical solutions have been used for protection against
this virus. Facemasks, social distancing, and hygiene are
the most widely used physical protective agents. A number
of natural food supplements and vitamins are also used for
strengthening the immune system, particularly vitamins D

and C, and propolis (Bachevski et al., 2020; Scorza et al.,
2020).
Propolis is a resinous honeybee product obtained
from beehives as a raw material. Honeybees mostly
collect propolis from the tree leaves, bark and trunk, then
transform it with various secretions and store it in the hive.
Honeybees benefit from propolis in physical, chemical and
biological terms (Bankova et al., 2019). They particularly
use it for antiseptic, antimicrobial, antiviral, antioxidant,
and antitumoral purposes. Propolis has been also
extensively employed in traditional and complementary
medicine on account of these wide-ranging biological
activities (Pasupuleti et al., 2017). Pharmacological and
biochemical studies in the last 30 years have shown that
propolis has a wide range of biologically active properties
such as antibacterial, antiviral, anti-inflammatory,
antitumoral, hepatoprotective, neuroprotective activities
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and immunity enhancement in apitherapeutic applications
(Pasupuleti et al., 2017; Bankova et al., 2019; Kolayli et al.,
2020).
Although its composition and bioactive properties
depend on the flora of the area where it is collected,
propolis consists of approximately 50% resin and balsam,
and 30% wax, while the rest is composed of essential
oils and aromatic compounds (Aliyazıcıoglu et al., 2011;
Bankova et al. 2019; Kızıltas and Erkan, 2020). The active
ingredients of propolis, which contains approximately 300
different organic compounds, are various polyphenols and
volatile compounds found in the balsamic part. Although
propolis is partially extracted by dissolution in water,
glycol, and vegetable oils, the optimal solvent is 60%–70%
ethanol (Oroian et al., 2020). Many different commercial
propolis extracts are currently available in different
forms, such as drops, sprays, pills, pastilles, etc. Higher
polyphenol or flavonoid-containing propolis samples are
regarded as high quality (Oroion et al., 2020). Polyphenols
are the largest class of phytochemical compounds,
and polyphenol-rich diets have been associated with
numerous health benefits. Studies strongly support the
idea of the use of dietary polyphenols in the prevention
of degenerative diseases, particularly cardiovascular
and neurodegenerative diseases and cancer (Tsao, 2010;
Pasupuleti et al., 2017).
Propolis is an excellent natural antimicrobial and
antiviral compound (Przybyłek and Karpiński, 2019).
Many studies have shown that propolis exerts an antiviral
effect against various DNA and RNA viruses, such as
HIV, Herpes simplex, HSV-1, HSV-2, para-influenza
virus, influenza virus type A and B, adenovirus, avian
reovirus, Newcastle virus disease, bovine rotavirus, and
pseudorabies virus (Bankova et al., 2014; Bachevskiet al.,
2020). The first study investigating the antiviral activity
of propolis against coronaviruses was conducted in 1990.
One in vitro study investigated only the antiviral effects
of five propolis flavonoids (chrysin, kaempferol, quercetin,
acacetin and galangin), and quercetin was observed to
exhibit dose-dependent antiviral activity (Debiaggi et al.,
1990).
During the COVID-19 pandemic, propolis and other
bee products have attracted renewed interest against
SARS-CoV-2 infection, and various molecular docking
studies have confirmed this. In silico studies have reported
that some of the active ingredients of propolis, especially
some flavonoids, have a higher binding potential than
antiviral drugs (hydroxychloroquine and remdesivir) used
in COVID-19 spike protein and ACE-2 (Mady et al., 2020;
Shaldam et al., 2020; Güler and Kara, 2020; Guler et al.,
2021). These studies have shown that the active components
of propolis also exhibit high binding potential to cellular

angiotensin-converting enzyme-2 (ACE-2) receptors
and the serine protease TMPRSS2 and PAK1 signaling
pathways (Beratta et al., 2020; Scorzaet al., 2020). A clinical
study in which propolis tablets were administered to PCRpositive Covid-19 patients (400 and 800 mg) (3×1) for
seven days together with placebo reported that propolis
shortened hospitalization times (Silveira et al., 2021).
Propolis also exhibits immunomodulatory and antithrombosis activities (Beratta et al., 2020), which are also
crucial in combating the virus. In addition, propolis has
been shown to inhibit the systemic inflammatory response
and to protect hepatic and neuronal cells in acute septic
shock (Korish and Arafa, 2011).
Although propolis is one of the most commonly used
natural prophylactic agents during the pandemic, scientific
studies on propolis are insufficient. The present study,
therefore, investigated the inhibitory effect of Anatolian
propolis against the COVID-19 virus for the first time
in terms of the spike S1 protein (SARS-CoV-2): ACE-2
inhibitor screening ELISA test as an in vitro study.
2. Materials and methods
2.1. Chemicals
The COVID-19 spike protein: ACE-2 assay ELISA kit
(Cat. No. 79954) was purchased from BPS Bioscience
(San Diego, CA, USA), while gallic acid, protocatechuic
acid p-OH benzoic acid, catechin, caffeic acid, syringic
acid, epicatechin, p-coumaric acid, ferulic acid, rutin,
myricetin, resveratrol, daidzein, luteolin, t-cinnamic acid,
hesperetin, chrysin, pinocembrin, caffeic acid phenethyl
ester (CAPE), FeSO4.7H2O, Folin–Ciocalteu’s phenol,
diethyl ether, ethyl acetate, and acetonitrile were purchased
from Sigma-Aldrich (Sigma-Aldrich Chemie, Munich,
Germany). Daidzein was obtained from from Cayman
Chemical (Michigan, USA) and ferric tripyridyltriazine
(Fe-III-TPTZ), FeCI3, CH3CO2Na.3H2O, acetonitrile from
Merck (Merck, Darmstadt, Germany).
2.2. Propolis samples
Two different propolis samples were used in this study.
Both propolis samples are examples of Anatolian flora,
one being prepared from raw Anatolian propolis, while
the other was Anatolian propolis used commercially.
Propolis samples from seven different regions (Van, Rize,
Zonguldak, Muğla, Antalya, Diyarbakır, and Giresun) were
mixed equally to obtain a homogeneous Anatolian propolis
sample (P1). Briefly, to 3 g of the powdered raw propolis
was added 30 mL 70% ethanol. This was then mixed in
a shaker at a controlled speed for 24 h (Heidolp Promax
2020, Schwabach, Germany), and ultrasonic (Everest
Ultrasonic, İstanbul, Turkey) extraction was applied for
30 min at a 99% power adjustment. The mixture was
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then filtered through 0.2 μm cellulose filters (Millipore,
Bedford, MA, USA). The ethanolic propolis extract of the
second sample selected from among commercial propolis
samples (P2) and was supplied by Bee&You (Bee’O)
(SBS Scientific Bio Solutions Inc., İstanbul, Turkey). The
commercial propolis extract is sold in pharmacies and
widely used for apitherapeutic purposes in Turkey. The
solid amounts in both propolis extracts were calculated
after evaporating the solvent and are expressed as mg /
mL. And also, all analyses of the propolis samples were
calculated as g extracts.
2.3. Characterization of the propolis samples
2.3.1. Total phenolic compounds (TPC)
The total phenolic content (TPC) values of both samples
were measured with Folin–Ciocalteu’s test using gallic acid
(GA) as standard (Singleton et al., 1999). Briefly, 20 µL of
six different propolis extracts, standard samples dilutions
(from 0.500 mg/mL to 0.015 mg/ml), and 0.2 N 400 µL
Folin reagents were mixed and completed to 5.0 mL with
distilled water, and then vortexed. After 3 min incubation,
400 µL of Na2CO3(10%) was added and incubated at 25
°C. The absorbance was measured at 760 nm after 2-h
incubation. The TPC was expressed in mg GAE/mL using
a standard curve.
2.3.2. Total flavonoid content
Total flavonoid concentrations of the propolis samples
were measured by the spectrophotometric method using
quercetin as standard (Fukumoto and Mazza, 2000).
Briefly, 250 mL of different propolis extracts and standard
dilutions (from 0.500 mg/mL to 0.015 mg/mL), 50 mL of
10% Al(NO3)3, and 50mL of 1 M NH4.CH3COO were mixed
and completed 3.0 mL with methanol (99%), vortexed
and incubated at 25 °C for 40 min. After incubation, the
absorbance was then measured against a blank at 415 nm.
The total flavonoid concentration was expressed in mg
QUE/g extract by the curve.
2.3.3. Determination ferric reducing/antioxidant power
(FRAP)
The total antioxidant capacities of the samples were
determined using the ferric reducing/antioxidant power
assay (FRAP) (Benzie &Strain, 1999). First, working
FRAP reagent (ferric tripyridyltriazine (Fe-III-TPTZ)
was prepared fresh by mixing 300 mM (pH: 3.6) acetate
buffer, 10 mM TPTZ, and 20 mM FeCl3 solutions in a ratio
of 10: 1: 1. Before the samples test, a standard curve was
prepared with 1000 µM stock FeSO4.7H2O solution by
serial dilutions. Next, 1.500 mL of the FRAP reagent, 50 µL
of sample and 50 µL methanol were mixed and incubated
for 4 min at 37 °C, and the absorbance was read at 595 nm
against a reagent blank containing distilled water. FRAP
values were expressed in µmol FeSO4.7H2O equivalents/g
extract.
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2.3.4. Determination of phenolic compositions by
HPLC-UV
For preparation of the propolis extracts for
chromatographic analysis, 10 mL of ethanolic extract was
evaporated, and the residue was dissolved using 10 mL of
pH2 purified water. The aqueous solution was extracted
three times with 5 mL of diethyl ether (15 min, 200 rpm,
25 °C) and three times with ethyl acetate (15 min, 200 rpm,
25 °C). The organic phase, which was collected in a flask
after each extraction, was evaporated. The residue was
then dissolved in 2 mL of methanol, filtered through 0.45
µm filters, and given to the HPLC device for analysis. The
phenolic content analysis of the samples was performed in
triplicate.
Phenolic content analysis of the samples was
performed at a 280 nm wavelength in the RP-HPLC
system (EliteLaChrome; Hitachi, Tokyo, Japan) with a C18
column (150 mm * 4.6 mm, 5 μm; Fortis). In the analysis
using 70% acetonitrile/water (A) and 2% acetic acid/water
(B) as mobile phase, the injection volume was 20 µL, the
flow rate was 1.00 mL/min, and the column temperature
was 30 °C. The analysis was performed using a gradient
program. The R2 values of the calibration curves of the
19 standard phenolic compounds used in the analysis
ranged between 0.998 and 1.000. The phenolic compound
concentrations were calculated in mg/100 g extracts.
2.4. Inhibition assay for Covid-19
The spike S1 (SARS-CoV-2): ACE-2 inhibitor screening
colorimetric assay kit (Cat. No. 79954) was purchased
from BPS Bioscience (79954, San Diego, CA USA). The
colorimetric test is designed for screening and profiling
inhibitors targeting the interaction between the spike
protein of SARS-CoV-2 and ACE-2. The aim of the
test is to determine the possible inhibitory potential of
tested samples for ACE-2 receptor and spike protein S1
interaction. Using the kit protocol, the absorbance was
read at 450 nm on a UV/Vis spectrophotometer microplate
reader. The propolis and standard phenolic samples were
diluted with 70% ethanol, and the Covid-19/ELISA test
procedure was then applied. All tests were performed in
triplicate. Inhibition values (IC50) of the propolis extracts
were calculated as µg of the extracts, but the pure phenolic
standards were calculated as mM.
2.5. Molecular docking studies
AutoDock 4.2.6 software for molecular docking studies
was used to investigate the possible interactions of eight
ligands and reference molecules with the target proteins.
The crystal structures of ACE-2 (PDB ID: 6M0J-chain
A, Res: 2.45 Å) and SARS-CoV-2 spike RBD (PDB ID:
6YLA-chain A, Res: 2.42 Å) were retrieved from RCSB
protein data bank at http://www.rscb.org. In order to
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evaluate the prediction of accuracy of the binding affinity
between ligands and two target proteins, the binding free
energies (ΔG) were calculated for the crystal structures
and the docking mode. The 3-D structures of all ligands
(pinocembrin, chrysin, cape, hesperetin, ferulic acid,
t-cinnamic acid, p-coumaric acid, and caffeic acid) and the
reference molecule (hydroxychloroquine) were retrieved
from the PubChem database (https://pubchem.ncbi.nlm.
nih.gov/) in sdf format and then converted to pdb format
using BIOVIA DS Visualizer software (Dassault Systèmes
BIOVIA, 2016).The prepared ligands and proteins were
used as input files for the AutoDock 4.2.6 software
(Morris et al., 2009). A Lamarckian genetic algorithm
method, implemented in the program AutoDock 4.2.6,
was employed. After energy minimization, the water
molecules were deleted, and the standard docking
procedure was used for a rigid protein and a flexible
ligand with torsion angles of 100 independent runs per
ligand. The receptor grid was generated using the grid
box panel in Autodock, by including active site amino
acid residues (Tyr449, Asn487, Gly496, Thr500, Gly502
andTyr505) of the spike RBD (Lan et al., 2020). However,
all docking experiments were performed as blind docking
(referring to the use of a grid box, which is large enough
to encompass any possible ligand-receptor complex) to
determine any interaction between targets and ligands. A
grid of 126, 126, and 126 points in x, y, and z directions was
built with a grid spacing of 0.375 Å. The default settings
of the software were applied for all other parameters. In
order to predict the binding strength of all ligands, the
ligand-protein docked complexes were analyzed based on
minimum binding energy values and ligand interaction
(hydrogen/hydrophobic) patterns. The final visualization
of the docked structures was performed using BIOVIA
Discovery Studio Visualizer 2018 (Dassault Systèmes
BIOVIA, 2016).
2.6. Pharmacokinetics and drug-likeness properties
(ADME prediction)
In order for a drug to be effective, it must reach its target
in the body in sufficient concentration and remain in

bioactive form long enough for the expected biological
events to occur there. Drug development involves
absorption, distribution, metabolism and excretion
(ADME) at an increasingly earlier stage in the discovery
process, at a stage when the compounds are abundant but
access to physical samples is limited (Daina et al., 2017).
The pharmacokinetics, drug-likeness, and medicinal
chemistry properties of eight ligands were predicted using
the SwissADME server. Important parameters related
to ADME properties, such as Lipinski’s five rules, drug
solubility, pharmacokinetic properties, molar refraction,
and drug-likeliness were analyzed. The SMILES format
retrieved from the PubChem Database of the relevant
ligands was used as input for the analysis tool (Daina et
al., 2017).
2.7 Statistical analyses
Statistical evaluations were carried out on SPSS version
11.5 software (IBM SPSS Statistics, Armonk, NY, USA).
Descriptive statistics were expressed as mean ± standard
deviation (SD). The correlation and difference analyses
were performed with Duncan’s multiple range test.
Significance was determined at p < 0.05.
3. Results
3.1. Propolis analyses
Table 1 shows the analysis of the two Anatolian propolis
samples, one prepared from raw Anatolian propolis (P1)
and the other a commercially available product (P2). The
solid matters of the ethanolic propolis extracts differed. The
commercial sample (P2) contained nearly twice as much
solid material as the other sample (P1). The pH values of
both propolis samples were between 4.50 and 4.80, and
both were acidic. TPC was 123.04 mg GAE/g extract in
sample P1 and 203.10 mg GAE/g extract in sample P2. The
phenolic compound content of the commercial sample
(P2) was approximately two-fold higher than that in P1.
Similarly, total flavonoid content also differed between
the two samples, being measured at 62.03 mg QUE/g
extract in P2 and 10.80 mg QUE/g extract in P1. The total
antioxidant capacities of the samples were investigated only

Table 1. Analysis of two Anatolian propolis samples.
Solid matter
in the extract pH
(mg/mL)
Ethanolic propolis
0.10 ± 0.00
extract
Commercial
P2
0.20 ± 0.01
Propolis (BEE’O)©

P1

Total phenolic
content
(mgGAE/g)

Total flavanoid Total antioxidant
content
capacity (FRAP)
(mgQUE/g)
(µmolFeSO4/g)
10.80 ± 0.30a

1414.00 ± 17.00a

4.50 ± 0.01 203.40 ± 15.00b 62.03 ± 4.90b

1427.00 ± 27.00b

4.80 ± 0.01 123.04 ± 0.20a

a, b letter(s) are significantly different (p < 0.05) by Duncan’s multiple range test.

533

GÜLER et al. / Turk J Biol
Table 2. Phenolic profile of the EPE samples by
HPLC-UV.
Phenolic Standards (mg/g)

(P1)

(P2)

Gallic acid

-

-

Protocathequic acid

-

-

p-OH Benzoic acid

-

-

Catechin

-

-

Caffeic acid

70.77

24.86

Syringic acid

-

-

Epicatechin

-

-

p-Coumaric acid

88.19

13.451

Ferulic Acid

37.85

7.29

Rutin

-

-

Myricetin

-

-

Resveratrol

-

Daidzein

-

-

Luteolin

-

-

t-Cinnamic acid

51.05

2.60

Hesperetin

71.10

151.47

Chrysin

66.51

59.54

Pinocembrin

168.55

90.21

CAPE

326.87

158.41

(-): not detected, P1:Ethanolic propolis extract
prepared by us, P2: Commercial propolis
supplied by (BEE’O).

through FRAP assay, and the total antioxidant capacities
were found similar. The phenolic profile results for the two
ethanolic propolis samples are summarized in Table 2. As
a result of the phenolic composition analyzes performed
by HPLC-UV, it was found that both propolis samples
contained similar types of phenolic compounds, but their
concentrations were different. According to the phenolic
standards examined in the present study, hesperetin was
found in higher amounts in the commercial sample (P2),
while pinosembrin, CAPE, and chrysin were found to be
higher in the P1 sample.
3.2. Molecular docking studies
The structures of the polyphenols used in the molecular
docking program are given in Figure 1. The binding free
energy values for ACE-2 and SARS-CoV-2 spike RBD
were calculated using the AutoDock 4.2.6 program and
are summarized in Table 3. The docked poses, interacting
residues and interactions of the four ligands with the
lowest binding energy with ACE-2 and SARS-CoV-2
spike RBD are given in Figures 2–9. Details concerning
the estimated binding affinities (kcal/mol) and Ki values
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of docked ligands are shown in the Table 3. The results
showed that four compounds (pinocembrin, chrysin,
caffeic acid phenethyl ester, and hesperetin) had very low
binding free energies to the ACE-2 receptor and SARSCoV-2 spike Protein RBD. It was also observed that
these four flavonoids have higher binding potentials than
hydroxychloroquine, which was used as a Covid-19 drug
and as the standard ligand in the present study. From the
Table 3, it can be clearly predicted that pinocembrin has
the highest binding energy value at –8.58 kcal/mol for
ACE-2 protein and –7.54 kcal/mol for SARS-CoV-2 spike
RBD, followed by chrysin, with dock scores of –8.47 and
–7.48 kcal/mol, respectively. The interactions in Figures
6 and 7 show that pinocembrin and chrysin form two
hydrogen bonds with Tyr449 residue in the active site of
SARS-CoV-2 spike protein RBD.
3.3 Pharmacokinetics and drug-likeness properties
Table 4 shows the ADME properties of the polyphenols
detected in the propolis samples. According to Lipinski,
a compound under consideration should possess five
properties in order to be selected as a potential drug (a) molecular mass <500 Daltons, (b) high lipophilicity
(expressed as LogP 5), (c) fewer than five hydrogen bond
donors, (d) fewer than 10 hydrogen bond acceptors, and
(e) molar refractivity between 40 and 130. The scanned
eight flavonoid compounds used in this study were all
found to satisfy Lipinski’s five conditions (Table 4). Other
properties like pharmacokinetic, physicochemical and
drug-likeness characteristics are shown in Table 4. The
results indicated that all eight molecules have the potential
to work effectively as novel drugs.
3.4. In vitro inhibition studies
The binding of ACE-2 protein to SARS-CoV-2 spike S1
protein was studied for both EPEs using the inhibitor
screening colorimetric assay kit (BPS Bioscience, 79954).
The key to this ELISA assay is the high sensitivity of
detection of ACE-2-Biotin protein by StreptavidinHRP. This technique is based on the binding of the active
ingredients of the propolis to this spike S1 protein/ACE2 complex and inhibition of the binding of the enzymelabeled second antibody to the protein. The presence of
enzyme activity (horseradish peroxidase) indicates the
absence of binding. The inhibition values are expressed in
terms of the IC50 value and as the amount of the propolis
that provides 50% inhibition. The relevant data are shown
in Figures 10–11. The ability of specific flavonoids to
inhibit the interaction of SARS-CoV-2 S1 spike protein
and ACE-2 was also tested together with the propolis
samples. The two EPE samples were found to cause
inhibition of interaction of SARS-CoV-2 S1 spike protein:
ACE-2 receptors, the degree of inhibition (IC50) varying
depending on the propolis concentration. The IC50 value
of the P2 sample was higher than that in the P1 sample.
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Table 3. Summary of estimated binding affinity (kcal/mol) and Ki values of docked ligands against ACE-2 and SARS-CoV-2 spike
receptor binding domain, and interacted residues in the binding sites.
Receptor name / PDB ID

Ligand name

Binding energy
Ki
(kcal/mol)

Pinocembrin

–8.58

Chrysin

–8.47

Angiotensin-Converting
Enzyme-2 (ACE-2)
EC: 3.4.17.23

CAPE
–8.42
(Caffeic acid phenethyl ester)
Hesperetin

–8.22

/

Ferulic acid

–5.65

t-Cinnamic acid

–5.65

p-coumaric acid

–5.63

Caffeic acid

–5.31

*Hydroxychloroquine

–7.90

Pinocembrin

–7.54

6M0J (Chain A)
Res: 2.45 Å

6YLA (Chain A)
Res: 2.42 Å

Asn210, Leu9, Pro565, Ser563, Leu91,
Val212, Val209
Asn210, Val212, Ser563, Glu564, Leu91,
623.53 nM
Leu95, Pro565, Val209
510.99 nM

677.67 nM Asn437, Ile291, Thr434, Phe438, Pro415

CAPE

–7.17

Ferulic acid

–6.93

Leu91, Ser63, Asn210, Asp206, Val209,
Trp566, Val212, Glu564, Pro565, Leu95
72.03 µM His540, Ile291, Pro289, Thr434, Glu430
Leu456, Trp477, Leu503, Trp165,
72.06 µM
Trp271, Lys481
Trp165, Pro500, Leu503, Leu456,
74.21 µM
Trp477, Lys481, Trp271
127.93 µM Leu73, Ala99, Leu100, Lys74, Asn103
Arg393, Phe390, Leu391, Asn394,
1.61 µM
His378, His401, Asp350
Asn448, Tyr449, Tyr451, Tyr495, Lys444,
2.99 µM
Phe497
3.29 µM
Asn448, Tyr449, Phe497, Tyr495
Ile472, Asp467, Phe456, Arg457, Pro491,
4.63 µM
Lys458, Gln474
Leu335, Phe338, Val367, Trp436, Gly339,
5.54 µM
Cys336
8.29 µM
Leu441, Tyr495

t-Cinnamic acid

–6.64

13.57 µM

Phe497, Lys444, Asn448, Tyr449, Tyr495

Caffeic acid

–6.43

19.36 µM

Leu441, Tyr495, Phe497

p-coumaric acid

–5.97

42.06 µM

*Hydroxychloroquine

–6.32

23.35 µM

Phe497, Tyr495, Leu441
Leu517, Tyr396, Val382, Phe392, Thr430,
Phe515

SARS-CoV-2 spike receptor Chrysin
binding domain
Hesperetin
/

Interacted residues with ligand

–7.48
–7.28

943.94 nM

*reference molecule

The inhibition effects of five different concentrations of
hesperetin, CAPE and pinocembrin were tested with the
ELISA plate assay. The inhibition values varied depending
on the concentration (Figure 10). Hesperetin emerged as
the best inhibitor against the SARS-CoV-2 S1 spike protein
and ACE-2, and had the lowest IC50 value (11.13 mM),
followed by pinocembrin and CAPE. When comparing in
silico and in vitro study results, pinocembrin had a high
inhibitory effect in the in silico study, whereas hesperetin
was more active in the in vitro study.
4. Discussion
Propolis is a natural bee product and a very good source of
polyphenols. The ideal extraction solvent for propolis rich
in phenolic acid and flavonoids is 70% ethanol. The most
characteristic analysis parameters for propolis are total

polyphenol, total flavonoid and phenolic content analysis.
The phenolic contents of the two ethanolic propolis samples
in the present study were similar in terms of composition
but differed in terms of quantities. The main reason for this
difference is the amount of the raw propolis used initially
when extracting with solvent (70%). In the P1 sample, 3 g
of raw propolis was prepared at a ratio of 1:10 in 30 mL 70%
alcohol. However, since the P2 sample was a commercial
product, it was unclear how much raw propolis had been
used, and it can only be stated with certainty that higher
quantities were employed than the P1 sample. It was not
known how much propolis was used in the commercial
propolis sample, and the solid content was calculated to
determine the solute content in the extract. As a result,
it was determined that the amount of soluble matter was
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Figure 1. 2-D structures of ligands used in the present study.

higher in the commercial sample, which indicates that
cruder propolis was used in the commercial sample.
However, the quality of raw propolis used in extraction is
also an important parameter (Yeo et al., 2015). Reported
TPC in Anatolian raw propolis samples varied from 115
mg GAE/g to 210 mg GAE/g in one study (Aliyazıcıoglu

536

et al., 2011). It was also reported that TPC varied from
55.75 to 91.32 mg GAE/g in Brazilian propolis (Andrade
et al., 2017), while in another study, TPC varied from 10 to
80 mg GAE/g in Azerbaijan propolis (Zehra et al., 2015).
These results show that TPC is a critical quality criterion,
and this quality also depends on the flora involved.

GÜLER et al. / Turk J Biol

Figure 2. Binding pose profile of pinocembrin in the target protein ACE-2 (A), blue shaped molecule represents the receptor
and yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension (3D) (C) interactions
analysis of ACE-2 protein with compound pinocembrin.
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Figure 3. Binding pose profile of chrysin in the target protein ACE-2 (A), blue shaped molecule represents the receptor and
yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension (3D) (C) interactions analysis
of ACE-2 protein with compound chrysin.

The composition of propolis extracts depends on many
factors such as the flora of the area where the raw propolis
is collected, the time of collection and the extraction
techniques. For this reason, it is not easy to standardize
propolis extracts. As a matter of fact, it has been reported
that the total amount of polyphenol found in Red propolis
collected from different regions is between 150 and 220
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mg GAE/g (Reis et al., 2020). Another study shows that
the type and concentration of the solvent used in the
preparation of propolis extracts affect the amount of TPC
in the extract (Devequi-Nunes et al., 2018). As a matter
of fact, in another experimental animal study conducted
two years ago with the same commercial propolis sample
used in the present study, it was reported that the propolis

GÜLER et al. / Turk J Biol

Figure 4. Binding pose profile of CAPE in the target protein ACE-2 (A), blue shaped molecule represents the receptor and
yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension (3D) (C) interactions analysis
of ACE-2 protein with compound CAPE.

extract contained 102 mg GAE/mL (El Adaouia Taleb et
al., 2020).
The samples were also identified as acidic, (pH <
6.0), and the acidity was derived from the organic acids
contained in the propolis. Caffeic acid, p-coumaric
acid, and ferulic acids were detected in both samples.
However, other studies have described gallic acid, caffeic
acid, coumaric acid, ferulic acid and syringic acid, and
protocatechuic acid as the major phenolic acids in propolis
samples (Aliyazıcıoglu et al., 2011; Yeo et al., 2015). No

gallic acid, protocatechuic acid, p-OH benzoic acid, or
syringic acid were detected in any sample although this
does not necessarily mean that there will be no gallic acid
in Anatolian propolis (Keskin et al., 2019). Since these
phenolic acids are highly polar compounds, they may not
have switched to ethanol with a lower polarity than water.
CAPE, pinocembrin, and chrysin were identified the most
abundant flavonoids in both samples in the present study.
CAPE is a polyphenol found mostly in propolis, with
high quantities indicating a better quality of propolis,
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Figure 5. Binding pose profile of hesperetin in the target protein ACE-2 (A), blue shaped molecule represents the receptor and
yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension (3D) (C) interactions analysis
of ACE-2 protein with compound hesperetin.

and possesses a wide range of bioactive properties such
as antioxidant, anti-inflammatory, and anti-tumoral
activities (Aliyazıcıoglu et al., 2011; Bankova et al., 2014;
Venkateswara et al., 2017; Bankova et al., 2019).
Pinocembrin, hesperetin, and chrysin were abundantly
present flavonoids in the EPEs. Flavonoids are the most
common and the largest plant polyphenolic obtained from
the everyday plant-source diet (Chun et al., 2007). They
have also been shown to be responsible for a variety of
biological properties, such as antioxidant, antibacterial,
antiviral, and anti-inflammatory activities. The estimated
amount of flavonoids consumed in the daily diet is
approximately 200 mg/day, consisting of 84% flavan-3ols, flavanones (7.6%), flavonols (7%), anthocyanidins
(1.6%), flavones (0.8%), and isoflavones (0.6%). However,
epidemiological studies conducted in populations with
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flavonoid-rich diets have shown a lower incidence of
cardiovascular damage (Cui et al., 2008). Studies have also
described propolis as a very good source of flavonoids
(Venkateswara et al., 2017; Kowacz and Pollack, 2020).
The consumption of propolis as a food supplement thus
provides high levels of polyphenols and flavonoids.
The antioxidant capacity of the EPEs was measured
based on the FRAP test, a very simple and easy to apply
method showing total antioxidant capacity. The higher the
FRAP value measured based on the reduction ability of the
Fe (III) TPTZ complex, the higher the antioxidant capacity
(Can et al., 2015). In the present study, the antioxidant
capacity of the commercial propolis sample (P2) was
approximately close to the P1 sample. Although the P2
sample contains approximately twice as much TPC, it is
thought that the close antioxidant capacity is due to the
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Figure 6. Binding pose profile of pinocembrin in the SARS-CoV-2 Spike receptor binding domain (A), blue shaped
molecule represents the receptor and yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and threedimension (3D) (C) interactions analysis of SARS-CoV-2 Spike RBD with compound pinocembrin.

high antioxidant properties of some polyphenols in the
phenolic profile of the P1 sample (Can et al. 2015; Kolaylı
et al., 2020).
Molecular docking is a crucial tool for exploring
the interactions between the target protein and a small

molecule. Binding energy (kcal/mol) data make it possible
to study and compare the binding affinities of different
ligands/compounds with their corresponding target
receptor molecules. Lower binding energy indicates a
higher affinity of the ligand for the receptor. The ligand
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Figure 7. Binding pose profile of chrysin in the SARS-CoV-2 Spike receptor binding domain (A), blue shaped molecule
represents the receptor and yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension
(3D) (C) interactions analysis of SARS-CoV-2 Spike RBD with compound chrysin.

with the highest affinity can be selected as a potential
drug for further investigation. For the present study, eight
flavonoids with a broad range of biological activities,
along with hydroxychloroquine, which exhibited efficacy
against SARS-CoV-2, were selected as ligands in order
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to investigate their binding affinities with SARS-CoV-2
spike protein RBD and ACE-2 as target receptor proteins.
All these eight polyphenols and one reference molecule
were individually docked to the ACE-2 and SARS-CoV-2
spike RBD. Following successful docking of all the ligands

GÜLER et al. / Turk J Biol

Figure 8. Binding pose profile of hesperetin in the SARS-CoV-2 Spike receptor binding domain (A), blue shaped molecule
represents the receptor and yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension
(3D) (C) interactions analysis of SARS-CoV-2 Spike RBD with compound hesperetin.

used in these docking experiments, the results revealed
significant interactions between the ligands and the target
receptors. Four ligands (pinocembrin, chrysin, CAPE,
and hesperetin) bound to the target protein ACE-2 more
effectively than the reference molecule. Additionally,
seven ligands (pinocembrin, chrysin, hesperetin, CAPE,
ferulic acid, t-cinnamic acid, and caffeic acid) bound
to the SARS-CoV-2 spike RBD more strongly than the
reference molecule, hydroxychloroquine. The results of
the docking study show that pinocembrin has the highest
binding energy values, –8.58 kcal/mol for ACE-2 protein
and –7.54 kcal/mol for SARS-CoV-2 Spike RBD, followed
by chrysin with docking scores of –8.47 and –7.48 kcal/
mol, respectively. Previous molecular docking studies
involving propolis and Covid-19 reported that some
propolis flavonoids exhibited high binding affinities to
ACE-2 receptors and the virus spike protein. For example,
quercetin and rutin have been reported to exhibit similar
activity (Basu et al., 2020; Guler and Kara, 2020; Mady et
al., 2020; Berretta et al., 2020). Another study compared the
binding of 10 flavonoids in ethanolic extracts of propolis to
ACE-II with that of MLN-4760, a known blocker of ACEII (Guler et al., 2021). Rutin, CAPE, myricetin, quercetin,
pinocembrin and hesperetin had stronger binding affinities
to ACE-II than that of the reference molecule (Guler et al.,
2021). In another study, docking analysis was performed
on 22 propolis compounds against SARS-CoV-2 main

protease (Mpro) and spike protein subunit 2 (S2), and four
were found to exhibit strong binding affinities (Harisna et
al., 2021).
Lipinski’s rule of five essentially determines the
molecular properties of a compound, namely the primary
requirement for being a potential drug, such as absorption,
distribution, metabolism, and excretion (ADME).
Generally, various parameters are used to evaluate
potential interactions between a drug and other non-drug
target molecules (Lipinski, 2004; Jayaram et al., 2012;
Das, et al., 2020; Gupta et al., 2020). The suitability for a
compound with a specific pharmacological or biological
activity to be used as a potential drug is evaluated. The
eight polyphenols detected in the propolis samples in the
present study met the conditions specified by Lipinski,
and other features were also compatible. We, therefore,
suggest that the flavonoids have the potential to function
effectively as novel drugs.
The aim of the present study, involving two propolis
extracts, was to investigate the inhibition potential of
ethanolic propolis extracts by binding to SARS-CoV-2
spike protein and ACE-2. In vitro study revealed that
both samples caused inhibition, but that the P2 sample
exhibited higher activity. We attributed this to the higher
polyphenol content of the P2 sample. The finding that
three polyphenols (hesperetin, pinocembrin and CAPE)
studied separately resulted in inhibition of the virus shows
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Figure 9. Binding pose profile of CAPE in the SARS-CoV-2 Spike receptor binding domain (A), blue shaped molecule
represents the receptor and yellow shaped molecule indicates the ligand. The two-dimension (2D) (B) and three-dimension
(3D) (C) interactions analysis of SARS-CoV-2 Spike RBD with compound CAPE.

that the active substances in propolis mostly derive from
flavonoids. Since no previous in vitro studies have been
published, we were unable to compare and discuss our
results. None of the eight phenolic standards were tested
in vitro by the ELISA KIT assay method, since the plate
was limited to 96 well plates. Following in silico study, the
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in vitro inhibitions of the three flavonoids with the highest
binding potential were examined.
When comparing in silico study results with in vitro
findings, pinocembrin, hesperetin, and CAPE were found
to exhibit high binding affinities to the virus spike S1 protein
and ACE-2 receptor. The in silico and in vitro studies, thus,

Table 4. ADME properties of ligands docked with SARS-CoV-2 Spike RBD and ACE-2 target proteins.
(Lipinski’s Rule of Five)
Aromatic
Mol.
H-bond H-bond Molar
Heavy
Rotat.
LogP
heavy
TPSA
weight
donor
acceptor Refractivity atoms
bonds
atoms

Pinocembrin

256.25 2.26

2

4

69.55

19

12

1

ESOL Class

Bio
GI
BBB
Pgp
PAINS Synthetic
Drug
Avail.
Violations
absorption permeant substrate
alerts Accessibility
Likeliness
Score

66.76 Å

soluble

High

Yes

No

0.55

0

2.96

No

Yes

High

Yes

No

0.55

0

2.93

No

Yes

Chrysin

254.24 2.5

2

4

71.97

19

16

1

70.67 Å

moderately
soluble

CAPE

284.31 3.26

2

4

80.77

21

12

6

66.76 Å

moderately
soluble

High

Yes

No

0.55

1

2.64

No

Yes

Hesperetin

302.28 1.91

3

6

78.06

22

12

2

66.76 Å

soluble

High

No

Yes

0.55

0

3.22

No

Yes

Ferulic acid

194.18 1.36

2

4

51.63

14

6

3

66.76 Å

soluble

High

Yes

No

0.85

0

1.93

No

Yes

t-Cinnamic acid

148.16 1.79

1

2

43.11

11

6

2

37.30 Å

soluble

High

Yes

No

0.85

0

1.67

No

Yes

p-coumaric acid

164.16 1.26

2

3

45.13

12

6

2

57.53 Å

soluble

High

Yes

No

0.85

0

1.61

No

Yes

Caffeic acid

180.16 0.93

3

4

47.16

13

6

2

77.76 Å

very soluble High

Yes

No

0.56

1

1.81

No

Yes

Lipinski’s rule of five: Molecular weight (<500 Da), LogP (<5), H-bond donor (<5), H-bond acceptor (<10), molar refractivity (40-13).
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Ligand name
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140
120
Inhibition (%)

Anatolian raw propolis (P1)

y = 32.172ln(x) + 157.98
R² = 0.9509

Commercial propolis (P2)

100
80

y = 26.098ln(x) + 124.77
R² = 0.9807

60
40

P1 IC50: 0.057 µg
P2 IC50: 0.035 µg

20
0

0

0.1

0.3
0.2
Concentration (µg)

0.4

0.5

Figure 10. Inhibition curves (IC50) of P1 and P2 for SARS-CoV-2 Spike S1 protein/ACE-2 protein complex.

120
100

Pinocembrin
Hesperetin

80
Inhibition (%)

CAPE

y = 33.656ln(x) - 31.156
R² = 0.992

y = 10.511ln(x) + 22.148
R² = 0.9519

60
40

y = 14.883ln(x) - 26.527
R² = 0.9249

20
0
-20
-40

0

10

20

30

40

Concentration (mM)

50

60
Hesperetin IC50: 11.13 mM
Pinocembrin IC50: 14.15 mM
CAPE IC50: 170.71 mM

Figure 11. Inhibition curves (IC50) of CAPE, pinocembrin and hesperetin for SARS-CoV-2 Spike S1 protein/
ACE-2 protein complex.

support one another. In addition, the phenolic standards
used in terms of ADME properties were found to exhibit
high drug properties, and the results proved that propolis
has a high potential in combating the Covid-19.
5. Conclusion
In this study, ethanolic Anatolia propolis extracts were
observed, for the first time in the literature, to inhibit
the Covid-19 virus in terms of binding spike S1 protein
and ACE-2 receptor in both in vitro and in silico studies.
However, there may be a need for more studies in the
future.

546

Acknowledgments
This work was funded by the KTU BAP FBA-2020-9192
project. We thank (Bee&You (Bee’O) (SBS Scientific Bio
Solutions Inc., İstanbul, Turkey) company for allowing the
use of commercial propolis sample.
Conflict of interest
No conflict of interest is declared.

GÜLER et al. / Turk J Biol
References
Aliyazıcıoglu R, Sahin H, Erturk O, Ulusoy E, Kolaylı S (2013).
Properties of phenolic composition and biological activity of
propolis from Turkey. International Journal of Food Properties
16: 277-287. doi: 10.1080/10942912.2010.551312
Andrade JKS, Denadai M, de Oliveira CS, Nunes ML, Narain N
(2017). Evaluation of bioactive compounds potential and
antioxidant activity of brown, green and red propolis from
Brazilian northeast region. Food Research International 101:
129-138. doi: 10.1016/j.foodres.2017.08.066
Bachevski D, Damevska K, Simeonovski V, Dimova V (2020). Back
to the basics: propolis and COVID-19. Dermatologic Therapy
33 (4): e13780. doi: 10.1111/dth.13780

Das S, Sarmah S, Lyndem S, Singha Roy A (2020). An investigation
into the identification of potential inhibitors of SARS-CoV-2
main protease using molecular docking study. Journal
of Biomolecular Structure and Dynamics 13: 1-11. doi:
10.1080/07391102.2020.1763201
Dassault Systèmes BIOVIA, Discovery Studio Modeling
Environment, Release 2017, San Diego: Dassault Systèmes,
2016.
Debiaggi M, Tateo F, Pagani L, Luini M et al. (1990). Effects of propolis
flavonoids on virus infectivity and replication. Microbiologica
13 (3): 207-213.

Bankova V, Bertelli D, Borba R, Conti BJ, da Silva Cunha IB et
al. (2019). Standard methods for Apis mellifera propolis
research. Journal of Apicultural Research. 58 (2): 1-49. doi:
10.1080/00218839.2016.1222661

Devequi-Nunes D, Machado Bas, De AbreuBarreto G, Silva JR,
Da Silva DF et al. (2018). Chemical characterization and
biological activity of six different extracts of propolis through
conventional methods and super critical extraction. PLoSOne
13 (12): e0207676. doi: 10.1371/journal.pone.0207676

Bankova V, Galabov AS, Antonova D, Vilhelmova N, Di Perri B
(2014). Chemical composition of propolis extract ACF® and
activity against herpes simplex virus. Phytomedicine. 21 (11):
1432-1438. doi: 10.1016/j.phymed.2014.04.026

El Adaouia Taleb R, Djebli N, Chenini H, Sahin H, Kolayli S (2020).
In vivo and in vitro anti-diabetic activity of ethanolic propolis
extract. Journal of Food Biochemistry 44 (7): e13267. doi:
10.1111/jfbc.13267

Basu A, Sarkar A, Maulik U (2020). Molecular docking study of
potential phytochemicals and their effects on the complex
of SARS-CoV2 spike protein and human ACE2. Scientific
Reports 10 (1): 1-15. doi: 10.1038/s41598-020-74715-4

Fukumoto LR, Mazza G (2000). Assessing antioxidant and prooxidant
activities of phenolic compounds. Journal Agriculture Food
Chemistry 48: 3597-3604. doi: 10.1021/jf000220w

Benzie IFF, Strain JJ (1999). Ferric reducing/antioxidant power assay:
direct measure of total antioxidant activity of biological fluids
and modiﬁed version for simultaneous measurement of total
antioxidant power and ascorbic acid concentration. Methods in
Enzymology 299: 15-27. doi: 10.1016/S0076-6879(99)99005-5
Berretta AA, Silveira MAD, Capcha JMC, DeJong D (2020). Propolis
and its potential against SARS-CoV-2 infection mechanisms
and COVID-19 disease. Biomedicine & Pharmacotherapy 131:
110622. doi: 10.1016/j.biopha.2020.110622
Çakir HE, Şirin Y, Kolayli S, Can Z (2018). Validation methods
for phenolic components with RP-HPLC-UV in various bee
products. Apiterapive Doğa Dergisi 1 (1): 13-19.
Can Z, Yildiz O, Sahin H, Turumtay EA, Silici S et al. (2015). An
investigation of Turkish honeys: their physico-chemical
properties, antioxidant capacities and phenolic profiles. Food
Chemistry 180: 133-141. doi: 10.1016/j.foodchem.2015.02.024

Güler Hİ, Kara Y (2020). Targeting CoV-2 Spike RBD: ACE-II
complex with phenolic compounds from Cistus (Cistus L.)
Bee Pollen for COVID-19 treatment by Molecular Docking
Study. Apiterapi ve Doğa Dergisi 3 (1): 10-23. doi: 10.35206/
jan.762734
Güler HI, Tatar G, Yildiz O, Belduz AO, Kolayli S (2021). Investigation
of potential inhibitor properties of ethanolic propolis extracts
against ACE-II receptors for COVID-19 treatment by
Molecular Docking Study. Archives of Microbiology. doi:
10.1007/s00203-021-02351-1
Gupta MK, Vemula S, Donde R, Gouda G, Behera L et al. (2020).
In-silico approaches to detect inhibitors of the human severe
acute respiratory syndrome corona virus envelope protein
ion channel. Journal of Biomolecular Structure 15: 1-11. doi:
10.1080/07391102.2020.1751300

Chun OK, Chung SJ, Song WO (2007). Estimated dietary flavonoid
intake and major food sources of US adults. The Journal of
Nutrition 137 (5): 1244-1252. doi: 10.1093/jn/137.5.1244

Harisna AH, Nurdiansyah R, Syaifie PH, Nugroho DW, Saputro KE
et al. (2021). In silico investigation of potential inhibitors to
main protease and spike protein of SARS-CoV-2 in propolis.
Biochemistry and Biophysics Reports 26: 100969. doi:
10.1016/j.bbrep.2021.100969

Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT et al. (2008).
Dietary flavonoid intake and lung cancer-A population-based
case-control study. Cancer 112 (10): 2241-2248. doi: 10.1002/
cncr.23398

Jayaram B, Singh T, Mukherjee G, Mathur A, Shekhar S et al. (2012).
Sanjeevini: A freely accessible web-server for target directed
lead molecule discovery. BMC Bioinformatics 13 (Suppl 17):
S7. doi: 10.1186/1471-2105-13-S17-S7

Daina A, Michielin O, Zoete V (2017). Swiss ADME: a free web tool
to evaluate pharmacokinetics, drug-likeness and medicinal
chemistry friendliness of small molecules. Scientific Reports 7:
42717. doi: 10.1038/srep42717

Keskin M, Keskin Ş, Kolayli S (2019). Preparation of alcohol free
propolis-alginate microcapsules, characterization and release
property. LWT-Food Science and Technology 108: 89-96. doi:
10.1016/j.lwt.2019.03.036

547

GÜLER et al. / Turk J Biol
Kiziltas H, Erkan C (2020). The effects of different beehives on
propolis production and quality. Food Science and Technology.
Ahead of Print. doi: 10.1590/fst.20120
Kolayli S, Palabiyik I, Atik DS, Keskin M, Bozdeveci A et al. (2020).
Comparison of antibacterial and antifungal effects of different
varieties of honey and propolis samples. Acta Alimentaria 49
(4): 515-523. doi: 10.1556/066.2020.49.4.18
Korish AA, Arafa MM (2011). Propolis derivatives inhibit the
systemic inflammatory response and protect the hepatic and
neuronal cells in acute septic shock. The Brazilian Journal
of Infectious Diseases 15 (4): 332-338. doi: 10.1016/S14138670(11) 70201-X
Kowacz M, Pollack GH (2020). Propolis-induced exclusion of
colloids: Possible new mechanism of biological action. Colloid
And Interface Science Communications 38: 100307. doi:
10.1016/j.colcom.2020.100307
Lan J, Ge J, Yu J, Shan S, Zhou H et al. (2020). Structure of the SARSCoV-2 spike receptor-binding domain bound to the ACE2
receptor. Nature 581: 215–220. doi: 10.1038/s41586-020-21805
Lipinski CA (2004). Lead- and drug-like compounds: The rule-offive revolution. Drug Discovery Today: Technologies 1 (4):
337–341. doi: 10.1016/j.ddtec.2004.11.007
Mady FM, Sarhan HA, Rateb HS et al. (2020). Optimization and
Evaluation of propolis liposomes as a promising therapeutic
approach for COVID-19. International Journal of Pharmaceutics
592: 120028. doi: 10.1016/j.ijpharm.2020.120028
Malkoç M, Çakir H, Kara Y, Can Z, Kolayli S (2019). Phenolic
composition and antioxidant properties of Anzer honey from
Black Sea Region of Turkey. Uludağ Arıcılık Dergisi 19 (2):
143-151. doi: 10.31467/uluaricilik.602906
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK et al.
(2009). AutoDock4 and AutoDockTools4: Automated docking
with selective receptor flexibility. Journal of Computational
Chemistry 30 (16): 2785-2791. doi: 10.1002/jcc.21256
Oroian M, Ursachi F, Dranca F (2020). Influence of ultrasonic
amplitude, temperature, time and solvent concentration on
bioactive compounds extraction from propolis. Ultrasonics
Sonochemistry 64: 105021. doi: 10.1016/j.ultsonch.2020.105021
Pasupuleti VR, Sammugam L, Ramesh N, Gan SH (2017). Honey,
propolis, and royal jelly: a comprehensive review of their
biological actions and health benefits. Oxidative Medicine and
Cellular Longevity 2017: 1259510. doi: 10.1155/2017/1259510

548

Przybyłek I, Karpiński TM (2019). Antibacterial properties of propolis.
Molecules 24 (11): 2047. doi: 10.3390/molecules24112047
Reis JHDO, Machado BAS, Barreto GDA, Anjos JPD, Fonseca
LMDS et al. (2020). Supercritical Extraction of Red Propolis:
Operational Conditions and Chemical Characterization.
Molecules 25 (20): 4816. doi: 10.3390/molecules25204816
Scorza CA, Gonçalves VC, Scorza FA, Fiorini AC, de Almeida ACG et
al. (2020). Propolis and coronavirus disease 2019 (COVID-19):
Lessons from nature. Complementary Therapies in Clinical
Practice 41: 101227. doi: 10.1016/j.ctcp.2020.101227
Shaldam MA, Yahya G, Mohamed NH, Abdel-Daim MM, Al
Naggar Y (2020). In silico screening of potent bioactive
compounds from honey bee products against COVID-19
target enzymes. ChemRxiv. 12644102: 1-18. doi: 10.26434/
chemrxiv.12644102.v1
Silveira MAD, De Jong D, dos Santos Galvão EB, Ribeiro JC, Silva
TC et al. (2021). Efficacy of propolis as an adjunct treatment
for hospitalized COVID-19 patients: a randomized, controlled
clinical trial. MedRxiv. doi: 10.1101/2021.01.08.20248932
Singleton VL, Orthofer R, Lamuela-Raventos RM (1999). Analysis of
total phenols and other oxidation substrates and antioxidants
by means of folin-ciocalteu reagent. Methods in Enzymology
299: 152-178. doi: 10.1016/S0076-6879(99)99017-1
Tsao

R (2010). Chemistry and biochemistry of dietary
polyphenols. Nutrients 2 (12): 1231-1246. doi: 10.3390/
nu2121231

Venkateswara RP, Kiran SDVS, Rohini P, Bhagyasree P (2017).
Flavonoid: a review on naringenin. Journal of Pharmacognosy
and Phytochemistry 6 (5): 2778-2783.
Yeo KL, Leo CP, Chan DJC (2015). Ultrasonic enhancement on
propolis extraction at varied pH and alcohol content. Journal
of Food Process Engineering 38 (6): 562-570. doi: 10.1111/
jfpe.12186
Zehra C, Yildiz O, Şahin H, Asadov A, Kolayli S (2015).
Phenolic profile and antioxidant potential of propolis from
Azerbaijan. Mellifera 15 (1): 16-28.
Zhu X, Ge Y, Wu T, Zhao K, Chen Y et al. (2020). Co-infection
with respiratory pathogens among COVID-2019 cases. Virus
Research 285: 198005. doi: 10.1016/j.virusres.2020.198005

